Pancreatic beta cells and islets take up thiamin by a regulated carrier-mediated process: Studies using mice and human pancreatic preparations

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 297, Issue 1, 2009, Pages

  Mee, Lisa ^a,b   Nabokina, Svetlana M ^a,b   Sekar, V Thillai ^a,b   Subramanian, Veedamali S ^a,b   Maedler, Kathrin ^c   Said, Hamid M ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BREMEN   (Germany)

Author keywords

Thiamin uptake; THTR 1; THTR 2; Transport regulation; TRMA

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CARRIER PROTEIN; PROTEIN TYROSINE KINASE; THIAMINE; THIAMINE TRANSPORTER 1; THIAMINE TRANSPORTER 2; UNCLASSIFIED DRUG;

ACTIVE TRANSPORT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE TRANSPORT; CELL METABOLISM; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEGALOBLASTIC ANEMIA; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PH; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TRANSPORT KINETICS;

ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; CALMODULIN; CELL LINE, TUMOR; FEEDBACK, BIOCHEMICAL; HUMANS; HYDROGEN-ION CONCENTRATION; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; KINETICS; MEMBRANE TRANSPORT MODULATORS; MEMBRANE TRANSPORT PROTEINS; MICE; MUTATION; PROTEIN-TYROSINE KINASES; THIAMINE; TISSUE CULTURE TECHNIQUES; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 67650032584     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00092.2009     Document Type: Article

References (46)

1. Alzahrani AS, Baitei E, Zou M, Shi Y. Thiamin transporter mutation: an example of monogenic diabetes mellitus. Eur J Endcrinol 155: 787-792, 2006.
2. Ashokkumar B, Vaziri N, Said HM. Thiamin uptake by the human-derived renal epithelial (HEK-293) cells: cellular and molecular mechanisms. Am J Physiol Renal Physiol 291: F796-F805, 2006.
3. Berdanier CD. Advanced Nutrition: Micronutrients. Boca Raton, FL: CRC, 1998.
4. Calingasan NY, Gandy SE, Baker H, Sheu KF, Smith JD, Lamb BT, Gearhart JD, Buxbaum JD, Harper C, Selkoe DJ, Price DL, Sisodia SS, Gibson GE. Noval neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency. Am J Pathol 149: 1063-1071, 1996.
5. 2+/ calmodulin-dependent protein kinase II, a brush border membrane protein. Proc Natl Acad Sci USA 87: 8990-8994, 1990.
6. Diaz GA, Banikazemi M, Oishi K, Desnick RJ, Gelb BD. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. Nat Genet 22: 309-312, 1999.
7. Dudeja PK, Tyagi S, Kavilaveettil RJ, Gill R, Said HM. Mechanism of thiamine uptake by human jejunal brush-border membrane vesicles. Am J Physiol Cell Physiol 281: C786-C792, 2001.
8. Fennelly J, Frank O, Baker H, Leevy CM. Peripheral neuropathy of the alcoholic: I. Aetiological role of aneurin and other B-complex vitamins. Br Med J 2: 1290-1292, 1964.
9. Fleming JC, Tartaglini E, Steinkamp MP, Schorderet DF, Cohen N, Neufeld EJ. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. Nat Genet 22: 305-308, 1999.
10. Frederikse PH, Farnsworth P, Zigler JS Jr. Thiamine deficiency in vivo produces fiber cell degeneration in mouse lenses. Biochem Biophys Res Commun 258: 703-707, 1999.
11. Gotah M, Maki T, Kiyoizumi T, Satomi S, Monaco AP. An improved method for isolation of mouse pancreatic islets. Transplantation 40: 437-438, 1985.
12. Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M. Benfotiamine blocks three major pathways of hyperglycemia damage and prevents experimental diabetic retinopathy. Nat Med 9: 294-299, 2003.
13. Helman B. Studies on obese-hyperglycemic mice. Ann NY Acad Sci 131: 541-558, 1965.
14. Hopfer U, Nelson K, Perotto J, Isselbacher KJ. Glucose transport in isolated brush border membrane from rat small intestine. J Biol Chem 248: 25-32, 1973.
15. Kumar CK, Moyer MP, Dudeja PK, Said HM. A protein-tyrosine kinase-regulated, pH-dependent, carrier-mediated uptake system for folate in human normal colonic epithelial cell line NCM460. J Biol Chem 272: 6226-6231, 1997.
16. Labay V, Raz T, Baron D, Mandel H, Williams H, Barrett T, Szargel R, McDonald L, Shalata A, Nosaka K, Gregory S, Cohen N. Mutations in SLC19A2 cause thiamine-response megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet 22: 300-304, 1999.
17. Leevy CM, Baker H. Vitamins and alcoholism. Am J Clin Nutr 21: 1325-1328, 1968.
18. Mandel H, Berant M, Hazani A, Naveh Y. Thiamine-dependent beriberi in the thiamine-responsive anemia syndrome. N Engl J Med 311:836-838, 1984.
19. Matsushima K, MacManus JP, Hakim AM. Apoptosis is restricted to the thalamus in thiamine-deficient rats. Neuroreport 8: 867-870, 1997.
20. Nabokina SM, Said HM. Characterization of the 5′-regulatory region of the human thiamin transporter SLC19A3: in vitro and in vivo studies. Am J Physiol Gastrointest Liver Physiol 287: G822-G829, 2004.
21. Neufeld EJ, Fleming JC, Tartaglini E, Steinkamp MP. Thiamin-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamin transport. Blood Cells Mol Dis 27: 135-138, 2001.
22. Oishi K, Kamakura S, Isazawa Y, Yoshimatsu T, Kuida K, Nakafuku M, Masuyama N, Gotoh Y. Male infertility due to germ cell apoptosis in mice lacking the thiamin carrier, Tht1. A new insight into the critical role of thiamin in spermatogenesis. Dev Biol 266: 299-309, 2004.
23. Prasannan KG, Sundaresan R, Venkatesan K. Thiamine deficiency and protein secretion by pancreatic slices in vitro. Experientia 33: 169-170, 1977.
24. Rathanaswami P, Pourany A, Sundaresan R. Effects of thiamine deficiency on the secretion of insulin and the metabolism of glucose in isolated rat pancreatic islets. Biochem Int 25: 577-583, 1991.
25. Rathanaswami P, Sundaresan R. Effects of thiamine deficiency on the biosynthesis of insulin in rats. Biochem Int 24: 1057-1062, 1991.
26. Reidling JC, Said HM. In vitro and in vivo characterization of the minimal promoter region of the human thiamin transporter SLC19A2. Am J Physiol Cell Physiol 285: C633-C641, 2003.
27. Reidling JC, Said HM. Adaptive regulation of intestinal thiamin uptake process: molecular mechanisms in wild-type and transgenic mice expressing the promoters of the human thiamin transporters hTHTR-1 and hTHTR-2. Am J Physiol Gastrointest Liver Physiol 288: G1127-G1134, 2005.
28. Reidling JC, Subramanian VS, Dudeja PK, Said HM. Expression and promoter analysis of SLC19A2 in the human intestine. Biochim Biophys Acta 1561: 180-187, 2002.
29. Rogers LE, Porter FS, Sidbury JB Jr. Thiamin-responsive megaloblastic anemia. J Pediatr 74: 494-504, 1969.
30. Said HM, Ghishan FK, Redha R. Folate transport by human intestinal brush-border membrane vesicles. Am J Physiol Gastrointest Liver Physiol 252: G229-G236, 1987.
31. Said HM, Ma TY, Grant K. Regulation of riboflavin intestinal uptake by protein kinase A: studies with Caco-2 cells. Am J Physiol Gastrointest Liver Physiol 267: G955-G959, 1994.
32. Said HM, Ortiz A, Kumar CK, Chatterjee N, Dudeja PK, Rubin S. Transport of thiamine in human intestine: mechanism and regulation in intestinal epithelial cell model Caco-2. Am J Physiol Cell Physiol 277: C645-C651, 1999.
33. Said HM. Recent advances in carrier-mediated absorption of water-soluble vitamins. Annu Review Physiol 66: 419-446, 2004.
34. Saito N, Kimura M, Kuchiba A, Itokawa Y. Blood thiamine levels in outpatients with diabetes mellitus. J Nutr Sci Vitaminol (Tokyo) 33: 421-430, 1987.
35. Singh M. Effect of thiamin deficiency on pancreatic acinar cell function. Am J Clin Nutr 36: 500-504, 1982.
36. Stagg AR, Fleming JC, Baker MA, Sakamoto M, Cohen N, Neufeld EJ. Defective high-affinity thiamine transporters leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts. J Clin Invest 103: 723-729, 1999.
37. Subramanian VS, Marchant JS, Parker I, Said HM. Cell biology of the human thiamine transporter-1 (hTHTR1): intracellular trafficking and membrane targeting. J Biol Chem 278: 3976-3984, 2003.
38. Subramanian VS, Marchant JS, Said HM. Targeting and intracellular trafficking of clinically relevant hTHTR1 mutations in human cell lines. Clin Sci (Lond) 113: 93-102, 2007.
39. Subramanian VS, Mohammed ZM, Molina A, Marchant JS, Vaziri ND, Said HM. Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE-19) cells: mechanism and regulation. J Physiol 582: 73-85, 2007.
40. Tallaksen CM, Bell H, Bohmer T. Thiamin and thiamin phosphate ester deficiency assessed by high performance liquid chromatography in four clinical cases of Wernicke encephalopathy. Alcohol Clin Exp Res 17: 712-716, 1993.
41. Tallaksen CME, Bohmer T, Bell H. Blood and serum thiamin and thiamin phosphate esters concentration in patients with alcohol dependence syndrome before and after thiamin treatment. Alcohol Clin Exp Res 16: 320-325, 1992.
42. Tanphaichitr V. Thiamin. In: Modern Nutrition in Health and Disease, edited by Shils ME, Olsen JA, Shike M. New York: Lea and Febiger, 1994, 359-375.
43. Thornalley PJ, Babaei-Jadidi R, Al Ali H, Rabbani N, Antonysunil A, Larkin J, Ahmed A, Rayman G, Bodmer CW. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 125: 771-774, 2007.
44. Valerio G, Franzese A, Poggi V, Patrini C, Laforenza U, Tenore A. Lipophilic thiamine treatment in long-standing insulin-dependent diabetes mellitus. Acta Diabetol 36: 73-76. 1999.
45. Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff Syndrome and Related Neurological Disorders Due to Alcoholism and Malnutrition. Philadelphia, PA: Davis, 1989.
46. Wilkinson GN. Statistical estimation in enzyme kinetics. Biochem J 80: 324-332, 1961.